Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 July 1989:
Vol. 245. no. 4916, pp. 379 - 385
DOI: 10.1126/science.2569235
Prev | Table of Contents | Next

Articles

Science, Vol 245, Issue 4916, 379-385
Copyright © 1989 by American Association for the Advancement of Science

articles

Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans

WR Schafer, R Kim, R Sterne, J Thorner, SH Kim, and J Rine

Department of Biochemistry, University of California, Berkeley 94720.

The activity of an oncoprotein and the secretion of a pheromone can be affected by an unusual protein modification. Specifically, posttranslational modification of yeast a-factor and Ras protein requires an intermediate of the cholesterol biosynthetic pathway. This modification is apparently essential for biological activity. Studies of yeast mutants blocked in sterol biosynthesis demonstrated that the membrane association and biological activation of the yeast Ras2 protein require mevalonate, a precursor of sterols and other isoprenes such as farnesyl pyrophosphate. Furthermore, drugs that inhibit mevalonate biosynthesis blocked the in vivo action of oncogenic derivatives of human Ras protein in the Xenopus oocyte assay. The same drugs and mutations also prevented the posttranslational processing and secretion of yeast a-factor, a peptide that is farnesylated. Thus, the mevalonate requirement for Ras activation may indicate that attachment of a mevalonate-derived (isoprenoid) moiety to Ras proteins is necessary for membrane association and biological function. These observations establish a connection between the cholesterol biosynthetic pathway and transformation by the ras oncogene and offer a novel pharmacological approach to investigating, and possibly controlling, ras-mediated malignant transformations.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
C. M. Shachaf, O. D. Perez, S. Youssef, A. C. Fan, S. Elchuri, M. J. Goldstein, A. E. Shirer, O. Sharpe, J. Chen, D. J. Mitchell, et al. (2007)
Blood 110, 2674-2684
   Abstract »    Full Text »    PDF »
Statin-Induced Breast Cancer Cell Death: Role of Inducible Nitric Oxide and Arginase-Dependent Pathways.
S. Kotamraju, C. L. Willams, and B. Kalyanaraman (2007)
Cancer Res. 67, 7386-7394
   Abstract »    Full Text »    PDF »
Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors..
A. E. Rusinol and M. S. Sinensky (2006)
J. Cell Sci. 119, 3265-3272
   Abstract »    Full Text »    PDF »
Lysine {beta}311 of Protein Geranylgeranyltransferase Type I Partially Replaces Magnesium.
H. L. Hartman, K. E. Bowers, and C. A. Fierke (2004)
J. Biol. Chem. 279, 30546-30553
   Abstract »    Full Text »    PDF »
The RAM1 gene encoding a protein-farnesyltransferase {beta}-subunit homologue is essential in Cryptococcus neoformans.
M. A. Vallim, L. Fernandes, and J. A. Alspaugh (2004)
Microbiology 150, 1925-1935
   Abstract »    Full Text »    PDF »
Mutagenesis Studies of Protein Farnesyltransferase Implicate Aspartate {beta}352 as a Magnesium Ligand.
J. S. Pickett, K. E. Bowers, and C. A. Fierke (2003)
J. Biol. Chem. 278, 51243-51250
   Abstract »    Full Text »    PDF »
Activation of Rac2 and Cdc42 on Fc and complement receptor ligation in human neutrophils.
M. Forsberg, P. Druid, L. Zheng, O. Stendahl, and E. Sarndahl (2003)
J. Leukoc. Biol. 74, 611-619
   Abstract »    Full Text »    PDF »
Monoterpene regulation of Ras and Ras-related protein expression.
S. A. Holstein and R. J. Hohl (2003)
J. Lipid Res. 44, 1209-1215
   Abstract »    Full Text »    PDF »
RAM2: an essential gene in the prenylation pathway of Candida albicans.
J. L. Song and T. C. White (2003)
Microbiology 149, 249-259
   Abstract »    Full Text »    PDF »
Isoprenylation of RhoB Is Necessary for Its Degradation. A NOVEL DETERMINANT IN THE COMPLEX REGULATION OF RhoB EXPRESSION BY THE MEVALONATE PATHWAY.
K. Stamatakis, E. Cernuda-Morollon, O. Hernandez-Perera, and D. Perez-Sala (2002)
J. Biol. Chem. 277, 49389-49396
   Abstract »    Full Text »    PDF »
Consequences of Mevalonate Depletion. DIFFERENTIAL TRANSCRIPTIONAL, TRANSLATIONAL, AND POST-TRANSLATIONAL UP-REGULATION OF Ras, Rap1a, RhoA, AND RhoB.
S. A. Holstein, C. L. Wohlford-Lenane, and R. J. Hohl (2002)
J. Biol. Chem. 277, 10678-10682
   Abstract »    Full Text »    PDF »
Limitation of heart growth in neonatal piglets by simvastatin and atorvastatin: comparison with pravastatin.
K. Satoh, F. Shirota, T. Tsunajima, C. J. Beinlich, H. E. Morgan, and K. Ichihara (2001)
Am J Physiol Heart Circ Physiol 280, H2746-H2751
   Abstract »    Full Text »    PDF »
Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336.
A. Reichert, N. Heisterkamp, G. Q. Daley, and J. Groffen (2001)
Blood 97, 1399-1403
   Abstract »    Full Text »    PDF »
Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview.
P. E. Blackshear (2001)
Toxicol Pathol 29, 105-116
   Abstract »    PDF »
Combination Therapy with the Farnesyl Protein Transferase Inhibitor SCH66336 and SCH58500 (p53 Adenovirus) in Preclinical Cancer Models.
L. L. Nielsen, B. Shi, G. Hajian, B. Yaremko, P. Lipari, E. Ferrari, M. Gurnani, M. Malkowski, J. Chen, W. R. Bishop, et al. (1999)
Cancer Res. 59, 5896-5901
   Abstract »    Full Text »    PDF »
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development.
E. K. Rowinsky, J. J. Windle, and D. D. Von Hoff (1999)
J. Clin. Oncol. 17, 3631-3652
   Abstract »    Full Text »    PDF »
Protein prenylation in spinach chloroplasts.
I. Parmryd, B. Andersson, and G. Dallner (1999)
PNAS 96, 10074-10079
   Abstract »    Full Text »    PDF »
Processing, Secretion, and Anti-HIV-1 Activity of IL-16 With or Without a Signal Peptide in CD4+ T Cells.
P. Zhou, K. Devadas, D. Tewari, A. Jegorow, and A. L. Notkins (1999)
J. Immunol. 163, 906-912
   Abstract »    Full Text »    PDF »
Comprehensive evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae utilizing the Genome Reporter Matrix(TM).
D. Dimster-Denk, J. Rine, J. Phillips, S. Scherer, P. Cundiff, K. DeBord, D. Gilliland, S. Hickman, A. Jarvis, L. Tong, et al. (1999)
J. Lipid Res. 40, 850-860
   Abstract »    Full Text »
Role of Farnesyltransferase in ABA Regulation of Guard Cell Anion Channels and Plant Water Loss.
Z. Pei, M. Ghassemian, C. M. Kwak, P. McCourt, and J. I. Schroeder (1998)
Science 282, 287-290
   Abstract »    Full Text »
Involvement of Ras/MAP Kinase in the Regulation of Ca2+ Channels in Adult Bullfrog Sympathetic Neurons by Nerve Growth Factor.
S. Lei, W. F. Dryden, and P. A. Smith (1998)
J Neurophysiol 80, 1352-1361
   Abstract »    Full Text »    PDF »
Roles of Prenyl Protein Proteases in Maturation of Saccharomyces cerevisiae a-Factor.
V. L. Boyartchuk and J. Rine (1998)
Genetics 150, 95-101
   Abstract »    Full Text »
Dual Roles for Ste24p in Yeast a-Factor Maturation: NH2-terminal Proteolysis and COOH-terminal CAAX Processing.
A. Tam, F. J. Nouvet, K. Fujimura-Kamada, H. Slunt, S. S. Sisodia, and S. Michaelis (1998)
J. Cell Biol. 142, 635-649
   Abstract »    Full Text »    PDF »
J-104,871, a Novel Farnesyltransferase Inhibitor, Blocks Ras Farnesylation In Vivo in a Farnesyl Pyrophosphate-Competitive Manner.
M. Yonemoto, T. Satoh, H. Arakawa, I. Suzuki-Takahashi, Y. Monden, T. Kodera, K. Tanaka, T. Aoyama, Y. Iwasawa, T. Kamei, et al. (1998)
Mol. Pharmacol. 54, 1-7
   Abstract »    Full Text »
Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.
W. W. Stark Jr., M. A. Blaskovich, B. A. Johnson, Y. Qian, A. Vasudevan, B. Pitt, A. D. Hamilton, S. M. Sebti, and P. Davies (1998)
Am J Physiol Lung Cell Mol Physiol 275, L55-L63
   Abstract »    Full Text »    PDF »
Ras-GRF Activates Ha-Ras, but Not N-Ras or K-Ras 4B, Protein in Vivo.
M. K. Jones and J. H. Jackson (1998)
J. Biol. Chem. 273, 1782-1787
   Abstract »    Full Text »    PDF »
Mevalonate-Dependent Inhibition of Transendothelial Migration and Chemotaxis of Human Peripheral Blood Neutrophils by Pravastatin.
S. Dunzendorfer, D. Rothbucher, P. Schratzberger, N. Reinisch, C. M. Kahler, and C. J. Wiedermann (1997)
Circ. Res. 81, 963-969
   Abstract »    Full Text »
Substrate specificity determinants in the farnesyltransferase beta -subunit.
C. E. Trueblood, V. L. Boyartchuk, and J. Rine (1997)
PNAS 94, 10774-10779
   Abstract »    Full Text »    PDF »
Ras2 and Ras1 Protein Phosphorylation in Saccharomyces cerevisiae.
J. L. Whistler and J. Rine (1997)
J. Biol. Chem. 272, 18790-18800
   Abstract »    Full Text »    PDF »
Direct Demonstration of Geranylgeranylation and Farnesylation of Ki-Ras in Vivo.
C. A. Rowell, J. J. Kowalczyk, M. D. Lewis, and A. M. Garcia (1997)
J. Biol. Chem. 272, 14093-14097
   Abstract »    Full Text »    PDF »
Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I.
F. L. Zhang, P. Kirschmeier, D. Carr, L. James, R. W. Bond, L. Wang, R. Patton, W. T. Windsor, R. Syto, R. Zhang, et al. (1997)
J. Biol. Chem. 272, 10232-10239
   Abstract »    Full Text »    PDF »
Post-translational Modification of H-Ras Is Required for Activation of, but Not for Association with, B-Raf.
T. Okada, T. Masuda, M. Shinkai, K.-i. Kariya, and T. Kataoka (1996)
J. Biol. Chem. 271, 4671-4678
   Abstract »    Full Text »    PDF »
Differential Effects of Monoterpenes and Lovastatin on RAS Processing.
R. J. Hohl and K. Lewis (1995)
J. Biol. Chem. 270, 17508-17512
   Abstract »    Full Text »    PDF »
Isoprenylation of Plant Proteins in Vivo.
C. A. Shipton, I. Parmryd, E. Swiezewska, B. Andersson, and G. Dallner (1995)
J. Biol. Chem. 270, 566-572
   Abstract »    Full Text »    PDF »
Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells.
G. James, J. Goldstein, M. Brown, T. Rawson, T. Somers, R. McDowell, C. Crowley, B. Lucas, A. Levinson, and J. Marsters Jr (1993)
Science 260, 1937-1942
   Abstract »    PDF »
The effect of posttranslational modifications on the interaction of Ras2 with adenylyl cyclase.
Y Kuroda, N Suzuki, and T Kataoka (1993)
Science 259, 683-686
   Abstract »    PDF »
Dolichol delays G1-arrest for one cell cycle in human fibroblasts subjected to depletion of serum or mevalonate.
O. Larsson and J. Wejde (1992)
J. Cell Sci. 103, 1065-1072
   Abstract »    PDF »
Identification of a prenylation site in delta virus large antigen.
J. Glenn, J. Watson, C. Havel, and J. White (1992)
Science 256, 1331-1333
   Abstract »    PDF »
Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene.
M Raymond, P Gros, M Whiteway, and D. Thomas (1992)
Science 256, 232-234
   Abstract »    PDF »
Dedicated Transporters for Peptide Export and Intercompartmental Traffic in the Yeast Saccharomyces cerevisiae.
K. Kuchler, H.M. Goransson, M.N. Viswanathan, and J. Thorner (1992)
Cold Spring Harb Symp Quant Biol 57, 579-592
   Abstract »    PDF »
Growth factors and cancer.
S. Aaronson (1991)
Science 254, 1146-1153
   Abstract »    PDF »
Coordination between Cell Growth and Cell Cycle Transit in Animal Cells.
A. Zetterberg and O. Larsson (1991)
Cold Spring Harb Symp Quant Biol 56, 137-147
   Abstract »    PDF »
Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the ras protein.
W. Schafer, C. Trueblood, C. Yang, M. Mayer, S Rosenberg, C. Poulter, S. Kim, and J Rine (1990)
Science 249, 1133-1139
   Abstract »    PDF »
Common modifications of trimeric G proteins and ras protein: involvement of polyisoprenylation.
A. Finegold, W. Schafer, J Rine, M Whiteway, and F Tamanoi (1990)
Science 249, 165-169
   Abstract »    PDF »
Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins.
M. Milburn, L Tong, A. deVos, A Brunger, Z Yamaizumi, S Nishimura, and S. Kim (1990)
Science 247, 939-945
   Abstract »    PDF »
Prenylated proteins: the structure of the isoprenoid group.
H. Rilling, E Breunger, W. Epstein, and P. Crain (1990)
Science 247, 318-320
   Abstract »    PDF »
Identification of geranylgeranyl-modified proteins in HeLa cells.
C. Farnsworth, M. Gelb, and J. Glomset (1990)
Science 247, 320-322
   Abstract »    PDF »
The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.
S. B. Long, P. J. Hancock, A. M. Kral, H. W. Hellinga, and L. S. Beese (2001)
PNAS 98, 12948-12953
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)